	A commentary on 'The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis' [Int J Surg (2023) 109:982-994]. Int J Surg Wang Q, Shi H, Sun Y, Feng W, Xu H, Wang H. PMID: 38668669 [PubMed - indexed for MEDLINE]
	A commentary on 'Risk factors for incident venous thromboembolism in patients with renal tumor and inferior vena cava tumor thrombus: A retrospective case-control study'. Int J Surg Feng J, Cao Y, Wei J. PMID: 38668667 [PubMed - indexed for MEDLINE]
	Canine Prostate Cancer: Current Treatments and the Role of Interventional Oncology. Vet Sci Gibson EA, Culp WTN. PMID: 38668436 [PubMed]
	Antibody-Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data. Curr Oncol Nathan P, Rajeh A, Noor M, Boldt G, Fernandes R. PMID: 38668075 [PubMed - indexed for MEDLINE]
	Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of Biomarkers: A Systematic Review. Curr Oncol Parrao D, Lizana N, Saavedra C, Larrañaga M, Lindsay CB, San Francisco IF, Bravo JC. PMID: 38668066 [PubMed - indexed for MEDLINE]
	Long-Term Oncological Outcomes after Nerve-Sparing Robot-Assisted Radical Prostatectomy for High-Risk Localized Prostate Cancer: A Single-Center, Two-Arm Prospective Study. Diagnostics (Basel) Spirito L, Chessa F, Hagman A, Lantz A, Celentano G, Sanchez-Salas R, La Rocca R, Olsson M, Akre O, Mirone V, Wiklund P. PMID: 38667449 [PubMed]
	Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette-GuÃ©rin Immunotherapy of Bladder Cancer. Cells Ibrahim OM, Kalinski P. PMID: 38667314 [PubMed - indexed for MEDLINE]
	In Silico and In Vitro Study of Isoquercitrin against Kidney Cancer and Inflammation by Triggering Potential Gene Targets. Curr Issues Mol Biol Iqbal S, Karim MR, Mohammad S, Ahn JC, Kariyarath Valappil A, Mathiyalagan R, Yang DC, Jung DH, Bae H, Yang DU. PMID: 38666938 [PubMed]
	Radiogenomics and Texture Analysis to Detect von Hippel-Lindau (VHL) Mutation in Clear Cell Renal Cell Carcinoma. Curr Issues Mol Biol Greco F, D'Andrea V, Beomonte Zobel B, Mallio CA. PMID: 38666933 [PubMed]
	Detection of bladder cancer cells using quantitative interferometric label-free imaging flow cytometry. Cytometry A Dudaie M, Dotan E, Barnea I, Haifler M, Shaked NT. PMID: 38666711 [PubMed - as supplied by publisher]
	Renal Cell Carcinoma as the Cause of Lower Inflow Congestion. Dtsch Arztebl Int Witte P, Gassenmaier T, Christ M. PMID: 38666673 [PubMed - indexed for MEDLINE]
	A population-based propensity score matching analysis of risk factors and the impact on survival associated with refusal of cancer-directed surgery in patients with prostate cancer. Sci Rep Tang Y, Gao Y, Zhang R, Li T, Yang Y, Huang L, Wei Y. PMID: 38664545 [PubMed - indexed for MEDLINE]
	An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer. Urol Oncol Knorr J, Lone Z, Werneburg G, Adler A, Agudelo J, Suryavanshi M, Campbell RA, Ericson K, Qiu H, Bajic P, Haber GP, Weight CJ, Ahern PP, Almassi N, Miller AW, Lee BH. PMID: 38664180 [PubMed - as supplied by publisher]
	Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery. Urol Oncol Gómez Del Cañizo C, González Ginel I, Martín-Arriscado Arroba C, de la Calle Moreno A, Hernández Arroyo M, Rodríguez Antolín A, Guerrero Ramos F. PMID: 38664179 [PubMed - as supplied by publisher]
	Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for Refining Pelvic Nodal Contouring Guidelines. Clin Oncol (R Coll Radiol) Singh M, Maitre P, Mody R, Murthy V. PMID: 38664178 [PubMed - as supplied by publisher]
	Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study. Eur Urol Oncol Flippot R, Telli T, Velev M, Fléchon A, De Vries-Brilland M, Turpin L, Bergman A, Turco F, Mahammedi H, Fendler WP, Giraudet AL, Josset Q, Montravers F, Vogel W, Gillessen S, Berardi Vilei S, Herrmann K, Kryza D, Paone G, Hadaschik B, Merlin C, Dufour PA, Bernard-Tessier A, Naoun N, Patrikidou A, Garcia C, Foulon S, Pagès A, Fizazi K. PMID: 38664139 [PubMed - as supplied by publisher]
	The State of Intermediate Clinical Endpoints as Surrogates for Overall Survival in Prostate Cancer in 2024. Eur Urol Oncol Miszczyk M, Rajwa P, Fazekas T, Briganti A, Karakiewicz PI, Rouprêt M, Shariat SF. PMID: 38664138 [PubMed - as supplied by publisher]
	Progression-directed Therapy in Oligoprogressive Castration-resistant Prostate Cancer: Final Results from the Prospective, Single-arm, Phase 2 MEDCARE Trial. Eur Urol Oncol Rans K, Joniau S, Berghen C, Goffin K, Dumez H, Haustermans K, De Meerleer G. PMID: 38664137 [PubMed - as supplied by publisher]
	Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial). J Nucl Med Nikitas J, Lam E, Booker KA, Fendler WP, Eiber M, Hadaschik B, Herrmann K, Hirmas N, Lanzafame H, Stuschke M, Czernin J, Steinberg ML, Nickols NG, Kishan AU, Calais J. PMID: 38664019 [PubMed - as supplied by publisher]
	Prospective Comparison of (68)Ga-NeoB and (68)Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer. J Nucl Med Duan H, Song H, Davidzon GA, Moradi F, Liang T, Loening A, Vasanawala S, Iagaru A. PMID: 38664016 [PubMed - as supplied by publisher]

Articles 1 - 20 / 160928

Page 1 of 8047



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy